eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells

Regulatory Peptides

Volumn 125, Issue 1-3, 2005, Pages 41-46

  Díaz Troya, Sandra ^a   Najib, Souad ^a   Sánchez Margalet, Víctor ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

l NIO; N monomethyl l arginine; Pancreastatin

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; KT 5823; LEUCINE; N METHYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PANCREASTATIN; SPERMIDINE; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEPATOMA CELL; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT;

AMINOQUINOLINES; ANIMALS; ARGININE; CALCIUM; CARBAZOLES; CARCINOMA, HEPATOCELLULAR; CELL ENLARGEMENT; CELL PROLIFERATION; CHROMOGRANIN A; CHROMOGRANINS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DNA; ENZYME INHIBITORS; GUANYLATE CYCLASE; INDOLES; ISOENZYMES; LEUCINE; LIVER; MAP KINASE SIGNALING SYSTEM; NERVE TISSUE PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; OMEGA-N-METHYLARGININE; ORNITHINE; PANCREATIC HORMONES; PEPTIDES; PHOSPHOLIPASE C; PROTEIN ISOFORMS; RATS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SPERMIDINE; THYMIDINE; TIME FACTORS;

EID: 9944227667     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.07.031     Document Type: Article

References (56)

1. K. Tatemoto, S. Efendic, V. Mutt, G. Makk, G.J. Feistner, and J.D. Barchas Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion Nature 324 1986 476 478
2. H. Winkler, and R. Fischer-Colbrie The chromogranin-A and chromogranin-B-the 1st 25 years and future perspectives Neuroscience 49 1992 497 528
3. A.L. Iacangelo, H.U. Affolter, L.E. Eiden, E. Herbert, and M. Grimes Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues Nature 323 1986 82 86
4. H.J. Wu, D.J. Rozansky, D.J. Parmer, B.M. Gill, and D.T. O'Connor Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expression J. Biol. Chem. 266 1991 13130 13134
5. G. Watkinson, M. Rogers, and A. Dockray Post-translational processing of chromogranin A: differential distribution of phosphorylated variants of pancreastatin and fragments 248-313 and 297-313 in bovine pancreas and ileum Biochem. J. 295 1993 649 654
6. S.D. Arden, N.G. Rutherford, P.C. Guest, W.J. Curry, E.M. Bailyes, and C.F. Johnston The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2 Biochem. J. 298 1994 521 528
7. M.H. Metz-Boutigue, P. Garcia-Sablone, R. Hogue-Angeletti, and D. Aunis Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites Eur. J. Biochem. 217 1993 247 257
8. L. Taupenot, K.L. Harper, and D.T. O'Connor The chromogranin- secretogranin family N. Engl. J. Med. 348 2003 1134 1149
9. 2+-dependent mechanism Biochem. J. 284 1992 659 662
10. V. Sánchez-Margalet, and R. Goberna Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes Regulatory Pept. 51 1994 215 220
11. V. Sánchez-Margalet, and C. González-Yanes Pancreastatin inhibits insulin action in rat adipocytes Am. J. Physiol. 275 1998 E1055 E1060
12. V. Sánchez-Margalet, M. Lucas, and R. Goberna Pancreastatin: further evidence for its consideration as a regulatory peptide J. Mol. Endocrinol. 16 1996 1 8
13. V. Sánchez-Margalet, J. Santos-Alvarez, C. Gonzalez-Yanes, and S. Najib Pancreastatin. Biological effects and mechanisms of action Adv. Exp. Med. Biol. 482 2000 247 262
14. C. González-Yanes, J. Santos-Alvarez, and V. Sánchez- Margalet Characterization of pancreastatin receptors and signaling in adipocyte membranes Biochim. Biophys. Acta 1451 1999 153 162
15. C. González-Yanes, and V. Sánchez-Margalet Pancreastatin modulates insulin signaling in rat adipocytes. Mechanisms of cross-talk Diabetes 49 2000 1288 1294
16. V. Sánchez-Margalet, M. Valle, and R. Goberna Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking Mol. Pharmacol. 46 1994 24 29
17. V. Sánchez-Margalet, and J. Santos-Alvarez Solubilization and molecular characterization of pancreastatin receptors from rat liver membranes Endocrinology 138 1997 1712 1718
18. V. Sánchez-Margalet, M. Lucas, and R. Goberna Pancreastatin action in the liver: dual coupling to different G proteins Cell. Signal. 8 1996 9 12
19. q/11α family in rat liver membranes Hepatology 27 1998 608 614
20. q/11-MEK pathway by interacting with specific receptors Eur. J. Pharmacol. 397 2000 229 235
21. V. Sánchez-Margalet Modulation of insulin receptor signalling by pancreastatin in HTC hepatoma cells Diabetologia 42 1999 317 325
22. 2+ in rat hepatocytes involving both pertussis toxin-sensitive and -insensitive mechanisms Biochem. J. 294 1993 439 442
23. V. Sánchez-Margalet, M. Lucas, and R. Goberna Pancreastatin activates protein kinase C by stimulating the formation of 1,2-diacylglycerol in rat hepatocytes Biochem. J. 303 1994 51 54
24. R. Bataller, J.M. Nicolas, P. Gines, A. Esteve, M. Nieves Gorbig, and E. Garcia-Ramallo Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells Gastroenterology 113 1997 615 624
25. T. Sugimoto, J. Kano, T. Yamaguchi, M. Fukase, and K Chihara Role of calcium/protein kinase C in the regulation of DNA synthesis by parathyroid hormone-related peptide in osteoblastic osteosarcoma cells Horm. Metab. Res. 25 1993 608 611
26. A. Kaneko, N. Hayashi, H. Tsubouchi, Y. Tanaka, T. Ito, and Y. Sasaki Intracellular calcium as a second messenger for human hepatocyte growth factor in hepatocytes Hepatology 15 1992 1173 1178
27. N.W. Morrel, P.D. Upton, S. Kotecha, A. Huntley, M.H. Yacoub, and J.M. Polak Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors Am. J. Physiol. 277 1999 L440 L448
28. L. Piacentini, M. Gray, N.Y. Honbo, J. Chentoufi, M. Bergman, and J.S. Karliner Endothelin-1 stimulates cardiac fibroblasts proliferation through activation of protein kinase C J. Mol. Cell. Cardiol. 32 2000 565 576
29. O.F. Dajani, D. Sandnes, O. Melien, F. Rezvani, L.S. Nilssen, and G.H. Thoresen Role of diacylglycerol (DAG) in hormonal induction of S phase in hepatocytes: the DAG-dependent protein kinase C pathway is not activated by epidermal growth factor (EGF), but is involved in mediating the enhancement of responsiveness to EGF by vasopressin, angiotensin II, and norepinephrine J. Cell. Physiol. 180 1999 203 214
30. V. Sánchez-Margalet, C. González-Yanes, and S. Najib Pancreastatin, a chromogranin A-derived peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hematoma cells J. Hepatol. 35 2001 80 85
31. B. Colombo, F. Curnis, C. Foglieni, A. Monno, G. Arrigoni, and A. Corti Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models Cancer Res. 62 2002 941 946
32. B. Eriksson, K. Oberg, and M. Stridsberg Tumor markers in neuroendocrine tumors Digestion 62 2000 33 38
33. B. Helpap, and J. Kollermann Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence? Virchows Arch. 438 2001 86 91
34. A. Iyoda, K. Hiroshima, T. Toyozaki, Y. Haga, T. Fujisawa, and H. Owada Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology Cancer 91 2001 1992 2000
35. C.K. Sung, V. Sánchez-Margalet, and I.D. Goldfine Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor, p62 and GTPase activating protein J. Biol. Chem. 269 1994 12503 12507
36. V. Sánchez-Margalet, I.D. Goldfine, C.J. Vlahos, and C.K. Sung Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, Ly294002 Biochem. Biophys. Res. Commun. 204 1994 446 452
37. J.P. Smith, S.T. Kramer, and S. Bagheri Effects of pancreastatin (24-49) on growth of normal pancreas and pancreatic cancer Pancreas 6 1991 551 557
38. D.S. Bredt, C.D. Ferris, and S.H. Snyder Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites J. Biol. Chem. 267 1992 10976 10981
39. V. Sánchez-Margalet, and R. Goberna Pancreastatin activates pertussis toxin-sensitive guanylate cyclase and pertussis toxin-insensitive phospholipase C in rat liver membranes J. Cell. Biochem. 55 1994 173 181
40. A. Sjoholm, A. Funakoshi, S. Efendic, C.G. Ostenson, and C. Hellerstrom Long term inhibitory effects of pancreastatin and diacepam binding inhibitor on pancreatic beta-cell deoxyribonucleic acid replication, polyamine content and insulin secretion Endocrinology 128 1991 3277 3282
41. G-hydroxy-l-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms Am. J. Physiol. 275 1998 R1256 R1264
42. D.C. Jenkins, I.G. Charles, L.L. Thomsen, D.W. Moss, L.S. Holmes, and S.A. Baylis Roles of nitric oxide in tumor growth Proc. Natl. Acad. Sci. U. S. A. 92 1995 4392 4396
43. Z. Wang, M. Wang, and B.I. Carr The inhibitory effect of interleukin 1 beta on rat hepatocyte DNA synthesis is mediated by nitric oxide Hepatology 28 1998 430 435
44. R.D. Curran, F.K. Ferrari, P.H. Kispert, J. Stadler, D.J. Stuehr, and R.L. Simmons Nitric oxide and nitric oxide generating compounds inhibit hepatocyte protein synthesis FASEB J. 5 1991 2085 2092
45. O. Kosonen, H. Kankaanranta, P. Vuorinen, and E. Moilanen Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives Eur. J. Pharmacol. 337 1997 55 61
46. S.-M. Yu, L.-M. Hung, and C.-C. Lin cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway Circulation 95 1997 1269 1277
47. A. Calderone, C.M. Thaik, N. Takahashi, D.L.F. Chang, and W.S. Colucci Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts J. Clin. Invest. 101 1998 812 818
48. J.D. Chiche, S.M. Schlutsmeyer, D.B. Bloch, S.M. de la Monte, J.D. Roberts Jr., and G. Filippov Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP J. Biol. Chem. 273 1998 34263 34271
49. R. Sarkar, D. Gordon, J.C. Stanley, and R.C. Webb Cell cycle effects of nitric oxide on vascular smooth muscle cells Am. J. Physiol. 272 1997 H810 H818
50. J.P. Guo, M.M. Panday, P.M. Consigny, and A.M. Lefer Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury Am. J. Physiol. 269 1995 H1122 H1131
51. D.L. Mooradian, T.C. Hutsell, and L.K. Keefer Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro J. Cardiovasc. Pharmacol. 25 1995 674 678
52. V. Sánchez-Margalet, and R. Goberna Pancreastatin activates pertussis toxin-sensitive guanylate cyclase and pertussis toxin-insensitive phospholipase C in rat liver membranes J. Cell. Biochem. 55 1994 173 181
53. T.L. Cornwell, E. Arnold, N.J. Boerth, and T.M. Lincoln Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP Am. J. Physiol. 267 1994 C1405 C1413
54. P. Sinnaeve, J.D. Chiche, Z. Nong, O. Varenne, N. Van Pelt, and H. Gillijns Soluble guanylate cyclase a1 and b1 gene transfer increases NO responsiveness and reduces neointima formation after ballon injury in rats via antiproliferative and antimigratory effects Circ. Res. 88 2001 103 109
55. S. Hanada, Y. Terada, S. Inoshita, S. Sasaki, S.M. Lohmann, and A. Smolenski Overexpression of protein kinase G using adenovirus inhibits cyclin E transcription and mesangial cell cycle Am. J. Physiol. 280 2001 F851 F859
56. E. Meacci, M. Taira, M. Moos Jr., C.J. Smith, M.A. Movesian, and E. Degeman Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase Proc. Natl. Acad. Sci. U. S. A. 89 1992 3721 3725